EP2763540A4 - COMPOSITIONS AND METHODS FOR EVALUATION AND TREATMENT OF DISEASES AND INFLAMMATORY DISORDERS - Google Patents

COMPOSITIONS AND METHODS FOR EVALUATION AND TREATMENT OF DISEASES AND INFLAMMATORY DISORDERS

Info

Publication number
EP2763540A4
EP2763540A4 EP12829361.0A EP12829361A EP2763540A4 EP 2763540 A4 EP2763540 A4 EP 2763540A4 EP 12829361 A EP12829361 A EP 12829361A EP 2763540 A4 EP2763540 A4 EP 2763540A4
Authority
EP
European Patent Office
Prior art keywords
diseases
evaluation
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12829361.0A
Other languages
German (de)
French (fr)
Other versions
EP2763540A1 (en
Inventor
Eran Elinav
Richard A Flavell
Till Strowig
Jorge H Mejia
Chengcheng Jin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yale University
Original Assignee
Yale University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yale University filed Critical Yale University
Publication of EP2763540A1 publication Critical patent/EP2763540A1/en
Publication of EP2763540A4 publication Critical patent/EP2763540A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP12829361.0A 2011-09-09 2012-04-16 COMPOSITIONS AND METHODS FOR EVALUATION AND TREATMENT OF DISEASES AND INFLAMMATORY DISORDERS Withdrawn EP2763540A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161532902P 2011-09-09 2011-09-09
US201261584988P 2012-01-10 2012-01-10
PCT/US2012/033753 WO2013036290A1 (en) 2011-09-09 2012-04-16 Compositions and methods for assessing and treating inflammatory diseases and disorders

Publications (2)

Publication Number Publication Date
EP2763540A1 EP2763540A1 (en) 2014-08-13
EP2763540A4 true EP2763540A4 (en) 2015-04-22

Family

ID=47832488

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12829361.0A Withdrawn EP2763540A4 (en) 2011-09-09 2012-04-16 COMPOSITIONS AND METHODS FOR EVALUATION AND TREATMENT OF DISEASES AND INFLAMMATORY DISORDERS

Country Status (2)

Country Link
EP (1) EP2763540A4 (en)
WO (1) WO2013036290A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2217250A4 (en) 2007-11-09 2011-01-05 California Inst Of Techn IMMUNOREGULATORY COMPOUNDS AND RELATED COMPOSITIONS AND METHODS
HUE040658T2 (en) 2010-04-07 2019-03-28 California Inst Of Techn Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems
EP2731617A4 (en) 2011-07-12 2015-07-01 Brigham & Womens Hospital LIPID-CONTAINING PSA COMPOSITIONS, METHODS OF ISOLATION AND METHODS OF USING SAME
ES2821383T3 (en) 2012-10-17 2021-04-26 Enterome Genetic signatures of inflammatory disorders related to the liver and Crohn's disease
EP2969012A4 (en) 2013-03-12 2016-09-14 Univ Yale COMPOSITIONS AND METHODS FOR IDENTIFYING MICROBES RELATED TO SECRETORY ANTIBODIES
WO2014182966A1 (en) * 2013-05-10 2014-11-13 California Institute Of Technology Probiotic prevention and treatment of colon cancer
US10920283B2 (en) 2013-11-01 2021-02-16 Washington University Methods to establish and restore normal gut microbiota function of subject in need thereof
FI127671B (en) 2014-05-28 2018-11-30 Filip Scheperjans A method for the diagnosis of Parkinson's disease
WO2016033439A2 (en) 2014-08-28 2016-03-03 Yale University Compositions and methods for the treating an inflammatory disease or disorder
US9968616B2 (en) 2014-10-25 2018-05-15 The Chinese University Of Hong Kong Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening
WO2016126831A1 (en) 2015-02-03 2016-08-11 Mayo Foundation For Medical Education And Research Methods and materials for assessing and treating arthritis
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
JP6918365B2 (en) 2015-08-19 2021-08-11 プレジデント アンド フェローズ オブ ハーバード カレッジ Lipidized PSA Compositions and Methods
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
JP2023531935A (en) * 2020-06-22 2023-07-26 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Treatment of obesity with G protein-coupled receptor 75 (GPR75) inhibitors

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045525A2 (en) * 2002-11-15 2004-06-03 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
WO2005016226A2 (en) * 2003-08-14 2005-02-24 Hadasit Medical Research Services & Development Ltd. Pharmaceutical compositions comprising ccr5 antagonists
WO2011043654A1 (en) * 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
WO2011082218A1 (en) * 2009-12-31 2011-07-07 Ira Milton Trachtman Compositions and method for treatment and prophylaxis of inflammatory bowel disease

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5023243A (en) 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
US5190931A (en) 1983-10-20 1993-03-02 The Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5168053A (en) 1989-03-24 1992-12-01 Yale University Cleavage of targeted RNA by RNAase P
US5459039A (en) 1989-05-12 1995-10-17 Duke University Methods for mapping genetic mutations
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5288644A (en) 1990-04-04 1994-02-22 The Rockefeller University Instrument and method for the sequencing of genome
ES2155822T3 (en) 1990-12-06 2001-06-01 Affymetrix Inc COMPOUNDS AND ITS USE IN A BINARY SYNTHESIS STRATEGY.
US5384261A (en) 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
DE69433180T2 (en) 1993-10-26 2004-06-24 Affymetrix, Inc., Santa Clara FIELDS OF NUCLEIC ACID PROBE ON ORGANIC CHIPS
US6159693A (en) 1998-03-13 2000-12-12 Promega Corporation Nucleic acid detection
US6270974B1 (en) 1998-03-13 2001-08-07 Promega Corporation Exogenous nucleic acid detection
US20090197249A1 (en) * 2004-11-01 2009-08-06 George Mason University Compositions and methods for diagnosing colon disorders
JP2012517822A (en) * 2009-02-19 2012-08-09 ガラパゴス・ナムローゼ・フェンノートシャップ Identification method and compound useful for diagnosis and treatment of diseases including inflammation
WO2011025962A1 (en) * 2009-08-28 2011-03-03 Dan Allison Antikine antibodies that bind to multiple cc chemokines

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004045525A2 (en) * 2002-11-15 2004-06-03 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation.
WO2005016226A2 (en) * 2003-08-14 2005-02-24 Hadasit Medical Research Services & Development Ltd. Pharmaceutical compositions comprising ccr5 antagonists
WO2011043654A1 (en) * 2009-10-05 2011-04-14 Aak Patent B.V. Methods for diagnosing irritable bowel syndrome
WO2011082218A1 (en) * 2009-12-31 2011-07-07 Ira Milton Trachtman Compositions and method for treatment and prophylaxis of inflammatory bowel disease

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DELPHINE M SAULNIER ET AL: "Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel Syndrome", GASTROENTEROLOGY, ELSEVIER, PHILADELPHIA, PA, vol. 141, no. 5, 24 June 2011 (2011-06-24), pages 1782 - 1791, XP028325678, ISSN: 0016-5085, [retrieved on 20110708], DOI: 10.1053/J.GASTRO.2011.06.072 *
ERAN ELINAV ET AL: "NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis", CELL, CELL PRESS, US, vol. 145, no. 5, 22 April 2011 (2011-04-22), pages 745 - 757, XP028221175, ISSN: 0092-8674, [retrieved on 20110502], DOI: 10.1016/J.CELL.2011.04.022 *
See also references of WO2013036290A1 *
YANFEI CHEN ET AL: "Characterization of fecal microbial communities in patients with liver cirrhosis", HEPATOLOGY, vol. 54, no. 2, 26 June 2011 (2011-06-26), pages 562 - 572, XP055159513, ISSN: 0270-9139, DOI: 10.1002/hep.24423 *
YOUNES J. ERRAHALI ET AL: "CCL26-Targeted siRNA Treatment of Alveolar Type II Cells Decreases Expression of CCR3-Binding Chemokines and Reduces Eosinophil Migration: Implications in Asthma Therapy", JOURNAL OF INTERFERON & CYTOKINE RESEARCH, vol. 29, no. 4, 1 April 2009 (2009-04-01), pages 227 - 239, XP055175655, ISSN: 1079-9907, DOI: 10.1089/jir.2008.0051 *

Also Published As

Publication number Publication date
WO2013036290A1 (en) 2013-03-14
EP2763540A1 (en) 2014-08-13

Similar Documents

Publication Publication Date Title
EP3494961C0 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC INFLAMMATION AND INFLAMMATORY DISEASES
FR23C1022I2 (en) BILE ACID RECYCLING INHIBITORS FOR THE TREATMENT OF PEDIATRIC HEPATIC CHOLESTATIC DISEASES
EP2726511A4 (en) COMPOSITIONS, USES AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS AND DISEASES
EP2877184A4 (en) COMPOSITIONS AND TREATMENT FOR DISEASES AND OCULAR DISORDERS
EP2709672A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF RETINA DISEASES
EP2875359A4 (en) COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS
EP2844636A4 (en) METHODS FOR THE TREATMENT OF DIABETIC RETINOPATHY AND OTHER OPHTHALMIC DISEASES
EP2800581A4 (en) METHODS OF TREATMENT OF BEHAVIORAL SYMPTOMS OF NEUROLOGICAL AND MENTAL DISORDERS
EP2900835A4 (en) METHODS AND COMPOSITIONS FOR DETECTING AND TREATING DEVELOPMENTAL DISORDERS
EP2691529A4 (en) METHODS AND COMPOSITIONS FOR TREATING CEREBRAL DISEASES
EP2382228A4 (en) COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
IL233212A0 (en) Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
EP2685987A4 (en) COMPOSITIONS AND METHODS USEFUL FOR IMPROVING AGE RELATED DISEASES
EP2525814A4 (en) METHODS OF TREATING OR PREVENTING PERIODONTITIS AND PARODONTIST-RELATED DISEASES
EP2429530A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEGENERATIVE AND ISCHEMIC DISORDERS
EP2723347A4 (en) PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS
EP2773342A4 (en) COMPOSITIONS USEFUL FOR THE TREATMENT OF VIRAL DISEASES
EP2717903A4 (en) TREATMENT METHODS FOR RETINAL DISEASES
EP2741771A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
EP2701694A4 (en) METHODS OF TREATING HEMOGLOBINOPATHIES
EP2836264A4 (en) APPARATUS AND METHODS FOR VENTILATORY TREATMENT
EP2720695A4 (en) AGENTS AND METHODS FOR THE TREATMENT OF ISCHEMIC DISEASES AND OTHER DISEASES
EP2911660A4 (en) COMPOSITIONS AND METHODS FOR TREATING STROGEN-RELATED MEDICAL DISORDERS
EP2750606A4 (en) METHODS OF DIAGNOSING AND TREATING NEUROLOGICAL AND NEURODEGENERATIVE DISEASES AND DISORDERS AND RELATED METHODS
EP2856172A4 (en) COMPOSITIONS AND METHODS FOR ANALYSIS OF PLATELET REACTIVITY AND TREATMENT SELECTION

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140409

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150319

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 63/00 20060101AFI20150313BHEP

17Q First examination report despatched

Effective date: 20160420

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20170315

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170726